Prognostic potential of circulating cell free mitochondrial DNA levels in COVID-19 patients

Mol Biol Rep. 2023 Dec;50(12):10249-10255. doi: 10.1007/s11033-023-08841-3. Epub 2023 Nov 7.

Abstract

Background: In viral infections, mitochondria act as one of the main hubs of the pathogenesis. Recent findings present new insights into the potential role of circulating cell-free mitochondrial DNA (ccf-mtDNA) in COVID-19 pathogenesis by the induction of immune response and aggressive cytokine storm in SARS-CoV-2 infection.

Methods and results: The levels of ccf-mtDNA were investigated in 102 hospitalized patients with COVID-19 using the quantitative PCR (q-PCR) method. Statistical analysis confirmed a strong association between the levels of ccf-mtDNA and and mortality, ICU admission, and intubation. Also, our findings highlighted the pivotal role of comorbidities as a risk factor for COVID-19 mortality and severity.

Conclusion: Higher levels of ccf-mtDNA can serve as a potential early indicator for progress and poor prognosis of COVID-19.

Keywords: COVID-19; Circulating mitochondrial DNA; Prognosis; SARS-CoV-2; Severity.

MeSH terms

  • COVID-19* / genetics
  • Cell-Free Nucleic Acids* / genetics
  • DNA, Mitochondrial / genetics
  • Humans
  • Mitochondria / genetics
  • Prognosis
  • SARS-CoV-2 / genetics

Substances

  • DNA, Mitochondrial
  • Cell-Free Nucleic Acids